Evaluation and Management of Low DHEAS with Previously Elevated Testosterone
The most likely diagnosis is PCOS with predominantly ovarian hyperandrogenism, and you should focus your evaluation on confirming PCOS while excluding rare but serious causes of hyperandrogenism including ovarian and adrenal neoplasms. 1
Clinical Context and Differential Diagnosis
Low DHEAS with previously elevated testosterone suggests ovarian-predominant androgen production rather than adrenal hyperandrogenism. This pattern is most consistent with PCOS, but you must systematically exclude life-threatening conditions before settling on this diagnosis 1.
The low DHEAS actually helps narrow your differential:
- PCOS remains most likely - approximately 67% of PCOS patients have normal DHEAS levels 2
- Ovarian neoplasm - produces testosterone without DHEAS elevation
- Ovarian hyperthecosis - LH-dependent testosterone elevation with normal DHEAS 3
Required Evaluation Algorithm
Step 1: Repeat Testosterone Measurement
Recheck early morning (8 AM) total testosterone on cycle days 4-10 if the patient has regular cycles 1. This timing is critical because testosterone norms are standardized to the follicular phase. If testosterone remains elevated (>2x upper limit of normal), proceed urgently with imaging 3.
Step 2: Exclude Neoplasm (Priority if Testosterone >2x Normal)
- Pelvic ultrasonography to detect ovarian neoplasm or polycystic ovaries 1
- If testosterone is markedly elevated with rapid virilization, 100% sensitivity exists for tumor detection when testosterone fails to suppress >40% on low-dose dexamethasone suppression test 4
- Normal DHEAS makes adrenal tumor unlikely, but if DHEAS were >600 µg/dL (16,000 nmol/L), abdominal CT would be mandatory 3
Step 3: Assess for PCOS Features
Look specifically for 1:
- Menstrual irregularity (oligomenorrhea, cycles >35 days, <8 cycles/year)
- Central obesity and metabolic markers: measure fasting glucose, insulin, lipid panel
- Acanthosis nigricans (insulin resistance marker)
- Family history of type 2 diabetes
Step 4: Additional Hormonal Testing
- Prolactin - exclude hyperprolactinemia 1
- 17-hydroxyprogesterone (early morning, follicular phase) - only if high-risk ethnicity for congenital adrenal hyperplasia (Ashkenazi Jewish, Hispanic, Slavic) 1
- Free testosterone and SHBG - if total testosterone is borderline or normal despite clinical hyperandrogenism 1
- Pregnancy test if amenorrheic 1
Step 5: Assess for Other Endocrinopathies (Only if Clinical Features Present)
- Cushing's syndrome screening if cushingoid features
- TSH if thyroid symptoms
- IGF-1 if acromegalic features 1
Key Clinical Pitfalls
Do not assume low DHEAS rules out significant pathology. While DHEAS >600 µg/dL suggests adrenal tumor 3, normal or low DHEAS with elevated testosterone can still indicate ovarian neoplasm 5. In one series, the positive predictive value of elevated testosterone for neoplasm was only 9%, but the negative predictive value was 100% 5.
Medication history is critical. Valproic acid is the only anticonvulsant that raises testosterone levels 1. Estrogen-containing medications increase SHBG and can mask free testosterone elevation 3.
Age matters for DHEAS interpretation. DHEAS declines by 40% from the twenties to thirties 2, so "low" DHEAS may be age-appropriate in older reproductive-age women.
Management Direction
If neoplasm is excluded and PCOS criteria are met (testosterone elevation + anovulation or polycystic ovaries on ultrasound), address the metabolic consequences of PCOS including screening for glucose intolerance, dyslipidemia, and cardiovascular risk factors 1. The low DHEAS pattern doesn't change PCOS management but suggests the hyperandrogenism is primarily ovarian rather than mixed ovarian-adrenal 2.
The pattern of low DHEAS with elevated testosterone in non-classic PCOS phenotypes (ovulatory or without polycystic ovaries) is associated with higher BMI and insulin resistance 2, making metabolic screening particularly important in this patient.